GO:0030111 regulation of Wnt signaling pathway: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030111 (regulation of Wnt signaling pathway) is a biological process defined as any process that modulates the frequency, rate or extent of the activity of the Wnt signal transduction pathway.
• Wnt signaling is controlled at multiple levels, including non-coding RNAs, RNA-binding proteins, RNA modifications, and metabolic inputs such as glycolysis [1,2,6,7].
• Dysregulation of Wnt signaling is linked to cancer, metabolic disorders, skeletal diseases, and impaired differentiation [3,4,5,7].
• Key regulatory nodes include RNF138, NSUN2, IL-33, and numerous RNA-binding proteins that modulate canonical Wnt activity [3,5,6,7].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect causal roles of Wnt regulators.
• Understanding GO:0030111 enables targeted therapeutic strategies in oncology, regenerative medicine, and metabolic disease.
Description
The Wnt signaling pathway is a conserved cascade controlling cell fate, proliferation, differentiation, and tissue homeostasis. Its activity is not static; it is continuously modulated by a diverse set of regulatory processes collectively annotated under the Gene Ontology term GO:0030111, regulation of Wnt signaling pathway. This term captures any process that modulates the frequency, rate or extent of Wnt signal transduction, encompassing both positive and negative regulators that act at the receptor, cytoplasmic, and nuclear levels [1,6,8]. Dysregulation of these regulatory mechanisms is a hallmark of many human diseases, making GO:0030111 a critical node for both basic and translational research [3,4,7]. Recent studies have expanded the repertoire of Wnt regulators beyond classical components to include non-coding RNAs, RNA-binding proteins, and metabolic enzymes, highlighting the complexity of this regulatory layer [2,6,7]. For researchers, precise annotation of GO:0030111 provides a framework to systematically interrogate how specific genes and perturbations alter Wnt output, enabling mechanistic insights and therapeutic targeting.
regulation of Wnt signaling pathway At A Glance
| GO ID | GO:0030111 |
|---|---|
| GO term | regulation of Wnt signaling pathway |
| Ontology | biological_process |
| Synonym | regulation of frizzled signaling pathway; regulation of Wnt receptor signaling pathway; regulation of Wnt-activated signaling pathway |
| Major function | Modulates the frequency, rate or extent of Wnt signal transduction |
| Related processes | Cell differentiation, proliferation, metabolism, and tissue homeostasis |
| Disease relevance | Cancer, metabolic disorders, skeletal diseases, and differentiation defects |
| Key regulators | Non-coding RNAs, RNA-binding proteins, RNF138, NSUN2, IL-33, and metabolic inputs |
What Is GO:0030111?
GO:0030111, regulation of Wnt signaling pathway, is defined as any process that modulates the frequency, rate or extent of the activity of the Wnt signal transduction pathway. This includes processes that activate, inhibit, or otherwise adjust the intensity and duration of Wnt signaling, whether through direct interaction with pathway components or through upstream signals that converge on the pathway.
Why Is regulation of Wnt signaling pathway Important in Cell Biology?
GO:0030111 is important because Wnt signaling is a central regulator of development and tissue homeostasis, and its dysregulation contributes to a wide range of pathologies. Understanding how this pathway is regulated at the molecular level provides opportunities to intervene in diseases such as cancer, where aberrant Wnt activity drives tumorigenesis, and in metabolic disorders where Wnt influences adipogenesis and energy balance [3,7,8]. Moreover, the regulatory mechanisms annotated under GO:0030111 are often tissue-specific and context-dependent, making them attractive targets for precision medicine [4,5].
• Wnt signaling controls cell fate decisions and is essential for embryonic development and adult tissue regeneration [1,4].
• Dysregulated Wnt signaling is a driver of many cancers, including hepatocellular carcinoma.
• Wnt signaling regulates adipogenesis and metabolic homeostasis, linking GO:0030111 to obesity and diabetes [3,8].
• Regulation of Wnt signaling is critical for osteoblast and chondrocyte differentiation, impacting bone diseases [2,4].
• Non-coding RNAs and RNA-binding proteins add layers of post-transcriptional control to Wnt signaling [2,6].
• RNA modifications such as m5C can modulate Wnt pathway activity in cancer.
• Skeletal muscle differentiation is regulated by Wnt/β-catenin signaling via E3 ubiquitin ligases like RNF138.
• Glycolytic activity can instruct germ layer proportions through regulation of Nodal and Wnt signaling.
• Targeting Wnt regulatory nodes offers therapeutic potential in oncology and regenerative medicine [7,8].
• CRISPR screens and functional genomics are powerful tools to identify novel regulators within GO:0030111.
What Happens During regulation of Wnt signaling pathway?
Extracellular and Receptor-Level Modulation
In simple terms: Signals outside the cell can turn Wnt signaling up or down by affecting the receptors or ligands.
Regulation of Wnt signaling begins at the extracellular level, where secreted modulators and non-coding RNAs can influence ligand availability and receptor activity. For example, non-coding RNAs have been shown to regulate Wnt signaling during osteoblast differentiation, affecting bone formation. Additionally, metabolic inputs such as glycolytic activity can instruct germ layer proportions through regulation of Nodal and Wnt signaling, demonstrating that cellular metabolism can impinge on Wnt pathway activity.
Intracellular Signal Transduction Control
In simple terms: Inside the cell, proteins can enhance or dampen the Wnt signal as it travels from the receptor to the nucleus.
Intracellular regulation involves a complex network of proteins that modify the stability and activity of key Wnt components. RNA-binding proteins have emerged as modulators of the canonical Wnt signaling pathway, influencing mRNA stability and translation of pathway genes. The E3 ubiquitin ligase RNF138 regulates skeletal muscle differentiation via the Wnt/β-catenin signaling pathway, highlighting the role of post-translational modifications in controlling Wnt output. Furthermore, IL-33 regulates adipogenesis via the Wnt/β-catenin/PPAR-γ signaling pathway in preadipocytes, illustrating cross-talk between inflammatory signals and Wnt regulation.
Nuclear and Transcriptional Feedback
In simple terms: In the nucleus, the Wnt signal leads to changes in gene expression that can feed back to adjust the pathway.
Nuclear regulation of Wnt signaling involves the transcriptional output of β-catenin target genes, which can include feedback regulators. NSUN2 regulates the Wnt signaling pathway depending on m5C RNA modification to promote hepatocellular carcinoma progression, indicating that epitranscriptomic modifications can influence nuclear events in Wnt signaling. This layer of regulation ensures that Wnt target gene expression is finely tuned in response to developmental and environmental cues.
Integration with Cellular Metabolism
In simple terms: The cell's metabolic state can directly influence how Wnt signaling behaves.
Wnt signaling is intricately linked to cellular metabolism. Glycolytic activity instructs germ layer proportions through regulation of Nodal and Wnt signaling, showing that metabolic flux can modulate Wnt pathway activity during differentiation. Additionally, Wnt signaling itself plays a role in regulating cell metabolism, as reviewed in the context of metabolic control. This integration ensures that Wnt responses are coordinated with the energetic and biosynthetic needs of the cell.
Key Genes Involved in GO:0030111 regulation of Wnt signaling pathway
The following genes and proteins are key players in the regulation of Wnt signaling pathway (GO:0030111), as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNF138 | E3 ubiquitin ligase regulating Wnt/β-catenin signaling | Skeletal muscle differentiation |
| NSUN2 | RNA m5C methyltransferase modulating Wnt signaling | Hepatocellular carcinoma progression |
| IL-33 | Cytokine regulating adipogenesis via Wnt/β-catenin/PPAR-γ | Obesity and metabolic disorders |
| CTNNB1 | Core component of Wnt signaling (β-catenin) | Central to pathway regulation and cancer [4,6] |
| FZD | Wnt receptor family | Receptor-level regulation [2,6] |
| LRP5/6 | Co-receptors for Wnt signaling | Modulation of canonical Wnt activity |
| DVL | Scaffold protein in Wnt signal transduction | Intracellular signal regulation |
| GSK3B | Kinase that phosphorylates β-catenin | Negative regulation of Wnt signaling |
| APC | Destruction complex component | Tumor suppressor in colorectal cancer |
| AXIN | Scaffold of β-catenin destruction complex | Negative regulator of Wnt |
| TCF/LEF | Transcription factors mediating Wnt target gene expression | Nuclear regulation |
| PPAR-γ | Nuclear receptor cross-talking with Wnt | Adipogenesis regulation |
| Nodal | TGF-β family member co-regulated with Wnt | Germ layer specification |
| Non-coding RNAs | Post-transcriptional regulators of Wnt | Osteoblast differentiation |
| RNA-binding proteins | Modulators of canonical Wnt signaling | Post-transcriptional control |
How Is regulation of Wnt signaling pathway Regulated?
Regulation of Wnt signaling pathway (GO:0030111) is itself subject to multiple layers of control. Non-coding RNAs can modulate Wnt activity during osteoblast differentiation. RNA-binding proteins influence the stability and translation of Wnt pathway mRNAs. RNA modifications, such as m5C mediated by NSUN2, can affect Wnt signaling in cancer. Metabolic inputs like glycolysis can instruct Wnt signaling during germ layer specification. Additionally, inflammatory cytokines such as IL-33 can regulate adipogenesis through Wnt/β-catenin/PPAR-γ signaling. These diverse regulatory mechanisms ensure that Wnt signaling is appropriately tuned to cellular context.
regulation of Wnt signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NSUN2 | Hepatocellular carcinoma | Knockout in liver cancer cell lines (e.g., HepG2) |
| IL-33 | Obesity / adipogenesis | Overexpression in preadipocytes |
| RNF138 | Skeletal muscle differentiation | Knockout in myoblast cell lines |
| CTNNB1 | Colorectal cancer and others | Point mutation knock-in in organoids |
| Non-coding RNAs | Osteoblast differentiation / bone disease | Overexpression or knockout in osteoblast precursors |
Cancer
Dysregulation of Wnt signaling is a common feature in many cancers. NSUN2 regulates the Wnt signaling pathway depending on m5C RNA modification to promote the progression of hepatocellular carcinoma, linking epitranscriptomic regulation of Wnt to liver cancer. Aberrant activation of Wnt/β-catenin signaling is also implicated in other malignancies, making regulators within GO:0030111 potential therapeutic targets [4,6].
Metabolic Disorders
Wnt signaling plays a critical role in adipogenesis and metabolic homeostasis. IL-33 regulates adipogenesis via the Wnt/β-catenin/PPAR-γ signaling pathway in preadipocytes, suggesting that modulation of Wnt signaling could influence obesity and related metabolic disorders. Additionally, Wnt signaling is involved in the regulation of cell metabolism, further linking GO:0030111 to metabolic diseases.
Skeletal Diseases
Regulation of Wnt signaling is essential for bone and cartilage development. Non-coding RNAs regulate Wnt signaling during osteoblast differentiation, and Wnt signaling controls osteoblasts and chondrocytes, with implications for osteoporosis and osteoarthritis [2,4]. RNF138 regulates skeletal muscle differentiation via the Wnt/β-catenin signaling pathway, indicating a broader role in musculoskeletal biology.
From regulation of Wnt signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RNF138 affect Wnt signaling and muscle differentiation? | RNF138 knockout in C2C12 myoblasts |
| Does NSUN2 m5C modification regulate Wnt in liver cancer? | NSUN2 knockout in hepatocellular carcinoma cells |
| How does IL-33 modulate adipogenesis via Wnt? | IL-33 overexpression in preadipocytes |
| What is the role of a specific non-coding RNA in osteoblast differentiation? | Non-coding RNA knockout or overexpression in osteoblast precursors |
| Does a point mutation in CTNNB1 alter Wnt signaling? | CRISPR knock-in of point mutation in cell lines |
| Can glycolysis influence Wnt signaling during differentiation? | Metabolic perturbation in stem cell models |
How to Study the regulation of Wnt signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes | Identify Wnt target genes and regulatory networks |
| m5C RNA IP | RNA methylation status | Study NSUN2-mediated Wnt regulation |
| Proteomics | Protein abundance and modifications | Analyze β-catenin stability and ubiquitination |
| Wnt reporter assay | Wnt signaling activity | Functional validation of regulators |
| CRISPR screen | Gene essentiality or activation | Discover novel Wnt regulators |
| Immunofluorescence | Protein localization | Assess β-catenin nuclear translocation |
| Co-immunoprecipitation | Protein-protein interactions | Map Wnt regulatory complexes |
Transcriptomic and Epitranscriptomic Profiling
RNA-seq and m5C RNA immunoprecipitation can reveal how regulators like NSUN2 affect Wnt target gene expression and RNA modification status. These methods help identify downstream effects of Wnt regulation at the transcript level.
Proteomic and Post-Translational Modification Analysis
Mass spectrometry-based proteomics can uncover changes in β-catenin stability, phosphorylation, and ubiquitination upon perturbation of regulators such as RNF138. This provides mechanistic insight into how Wnt signaling is modulated at the protein level.
Reporter Assays and Imaging
Wnt-responsive luciferase reporters and fluorescence microscopy can quantify pathway activity and localization of components like β-catenin in live cells. These assays are useful for functional validation of regulatory genes.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify novel regulators of Wnt signaling under specific conditions, such as during differentiation or in cancer cells [1,4]. These unbiased approaches expand the list of genes within GO:0030111.
How CRISPR Can Be Used to Study GO:0030111 regulation of Wnt signaling pathway
Knockout
CRISPR knockout of candidate regulators such as RNF138 or NSUN2 can determine their necessity for Wnt signaling and downstream phenotypes like differentiation or proliferation [5,7]. Knockout models are essential for loss-of-function studies within GO:0030111.
Point Mutation
Introducing precise point mutations in genes like CTNNB1 can mimic disease-associated variants and reveal how specific residues affect Wnt signaling regulation. This approach helps dissect mechanistic details of pathway modulation.
Knock-in
Knock-in of tagged versions of Wnt components (e.g., GFP-β-catenin) allows real-time tracking of protein dynamics and interactions, providing insights into regulatory mechanisms. Knock-in models are valuable for studying endogenous regulation.
Overexpression
Overexpression of regulators like IL-33 or non-coding RNAs can test sufficiency in driving Wnt-dependent processes such as adipogenesis or osteoblast differentiation [2,3]. This complements loss-of-function approaches.
How EDITGENE Supports regulation of Wnt signaling pathway Research
Researchers studying regulation of Wnt signaling pathway-related genes often need to determine whether a candidate gene is causally involved in modulating Wnt activity. EDITGENE provides comprehensive CRISPR-based services to enable such functional studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of Wnt signaling pathway research.
Frequently Asked Questions About regulation of Wnt signaling pathway
What is GO:0030111?
GO:0030111 is the Gene Ontology term for regulation of Wnt signaling pathway, defined as any process that modulates the frequency, rate or extent of the activity of the Wnt signal transduction pathway.
What genes are involved in regulation of Wnt signaling pathway?
Key genes include RNF138, NSUN2, IL-33, CTNNB1, and various non-coding RNAs and RNA-binding proteins [2,3,5,6,7].
How is Wnt signaling regulated?
Wnt signaling is regulated at multiple levels, including extracellular modulators, intracellular signal transduction control, nuclear feedback, and integration with cellular metabolism [1,2,6,8].
What diseases are associated with dysregulation of Wnt signaling?
Dysregulation of Wnt signaling is linked to cancer, metabolic disorders, and skeletal diseases [3,4,7].
What methods are used to study regulation of Wnt signaling?
Common methods include RNA-seq, proteomics, Wnt reporter assays, and CRISPR screens [1,5,6,7].
How can CRISPR be used to study Wnt signaling regulation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of Wnt regulators [2,3,4,5].
What is the role of non-coding RNAs in Wnt signaling?
Non-coding RNAs regulate Wnt signaling during processes such as osteoblast differentiation.
How does metabolism influence Wnt signaling?
Glycolytic activity can instruct germ layer proportions through regulation of Nodal and Wnt signaling.
What is the link between Wnt signaling and cancer?
NSUN2 regulates Wnt signaling via m5C modification to promote hepatocellular carcinoma progression.
How does IL-33 regulate adipogenesis?
IL-33 regulates adipogenesis via the Wnt/β-catenin/PPAR-γ signaling pathway in preadipocytes.
Conclusion
GO:0030111, regulation of Wnt signaling pathway, encompasses a diverse array of mechanisms that fine-tune Wnt activity in development, homeostasis, and disease. From non-coding RNAs and RNA-binding proteins to metabolic inputs and epitranscriptomic modifications, the regulatory landscape is complex and context-dependent [1,2,6,7]. Understanding these processes is essential for developing targeted therapies in cancer, metabolic disorders, and skeletal diseases [3,4,5]. CRISPR-based models and functional genomics provide powerful tools to dissect these regulatory networks and identify new therapeutic targets.
References
- 1. Stapornwongkul KS et al.. 2025. Glycolytic activity instructs germ layer proportions through regulation of Nodal and Wnt signaling.. Cell Stem Cell 32(5):744-758.e7 PMID: 40245870
- 2. Saranya I et al.. 2022. Regulation of Wnt signaling by non-coding RNAs during osteoblast differentiation.. Differentiation 128:57-66 PMID: 36370525
- 3. Xu D et al.. 2024. IL-33 regulates adipogenesis via Wnt/β-catenin/PPAR-γ signaling pathway in preadipocytes.. J Transl Med 22(1):363 PMID: 38632591
- 4. Nishimura R et al.. 2019. [Regulation of osteoblasts and chondrocytes by Wnt signaling.].. Clin Calcium 29(3):299-307 PMID: 30814374
- 5. Wang W et al.. 2025. RNF138 regulates skeletal muscle differentiation via the Wnt/β-catenin signaling pathway.. Theranostics 15(10):4446-4464 PMID: 40225576
- 6. Czap MS et al.. 2025. RNA-Binding Proteins: Modulators of Canonical Wnt Signaling Pathway.. Int J Mol Sci 27(1) PMID: 41516083
- 7. Xing H et al.. 2024. NSUN2 regulates Wnt signaling pathway depending on the m5C RNA modification to promote the progression of hepatocellular carcinoma.. Oncogene 43(47):3469-3482 PMID: 39375506
- 8. Koziński K et al.. 2013. [Wnt signaling pathway--its role in regulation of cell metabolism].. Postepy Hig Med Dosw (Online) 67:1098-108 PMID: 24379251
